Bitdeer Technologies Group's Q2 Net Loss Widens, Revenue Increases-February 2024-www.financetom.com

Bitdeer Technologies Group's Q2 Net Loss Widens, Revenue Increases

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Bitdeer Technologies Group's Q2 Net Loss Widens, Revenue Increases

Aug 18, 2025 5:01 AM

07:34 AM EDT, 08/18/2025 (MT Newswires) -- Bitdeer Technologies Group ( BTDR ) reported a Q2 net loss Monday of $0.76 per diluted share, widening from its loss of $0.14 per share a year earlier.

Analysts polled by FactSet expected a loss of $0.12 per share.

Revenue for the quarter ended June 30 was $155.6 million, compared with $99.2 million a year earlier.

Analysts polled by FactSet expected $106.5 million.

Previous page： Mobileye Global Stock Is Sliding Thursday: What's Going On? Next page： Google agrees $36 million fine for anti-competitive deals with Australia telcos

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Mobileye Global Stock Is Sliding Thursday: What's Going On?

Jul 10, 2025

Mobileye Global Inc ( MBLY ) shares are trading lower Thursday after the company announced a secondary offering of 50 million shares. What Happened: Mobileye priced a secondary offering of 50 million shares by an Intel Corp ( INTC ) subsidiary at $16.50 per share. The wholly owned Intel ( INTC ) subsidiary, Intel Overseas Funding Corp, also granted the...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Ascentage Pharma Says China Regulator Approves Treatment for Chronic Lymphocytic Leukemia

Jul 10, 2025

09:52 AM EDT, 07/10/2025 (MT Newswires) -- Ascentage Pharma ( AAPG ) said Thursday that lisaftoclax has been approved by China's National Medical Products Administration for the treatment of adult patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who have previously received at least one systemic therapy, including Bruton's tyrosine kinase inhibitors. Lisaftoclax is the first Bcl-2 inhibitor to receive conditional...

Intuitive Surgical Says Vessel Sealer Electrosurgical Instrument Gets FDA Approval

Jul 10, 2025

09:53 AM EDT, 07/10/2025 (MT Newswires) -- Intuitive Surgical ( ISRG ) said Thursday the US Food and Drug Administration approved its Vessel Sealer Curved, an electrosurgical instrument that is designed to seal, cut, grasp, and dissect tissue, for use with the company's da Vinci systems. The company said this is its first advanced energy instrument to obtain FDA clearance...